TANG v. EASTMAN KODAK COMPANY

CourtDistrict Court, D. New Jersey
DecidedMay 27, 2021
Docket3:20-cv-10462
StatusUnknown

This text of TANG v. EASTMAN KODAK COMPANY (TANG v. EASTMAN KODAK COMPANY) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
TANG v. EASTMAN KODAK COMPANY, (D.N.J. 2021).

Opinion

*NOT FOR PUBLICATON*

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY _______________________________________

TIANDONG TANG, individually and on behalf of all others similarly situated,

Plaintiff,

Civil Action No. 3:20-cv-10462-FLW-ZNQ v.

OPINION EASTMAN KODAK COMPANY, JAMES V. CONTINENZA, and DAVID BULLWINKLE,

Defendants.

WOLFSON, Chief Judge: Plaintiff Tiandong Tang sues Eastman Kodak Company (“Kodak”), James Continenza, and David Bullwinkle (collectively, “Defendants”), individually and on behalf of others similarly situated, for securities violations arising from a $765 million government loan to Kodak to manufacture COVID-19 drugs. Before the Court are three motions to be lead plaintiff1 and a motion to transfer this matter to a different venue. For the following reasons, I find that the Western District of New York is the most appropriate forum, and decline to decide the lead plaintiff motions. I. FACTUAL BACKGROUND AND PROCEDURAL HISTORY

A. Defendants’ Course of Conduct

1 The following parties withdrew their lead plaintiff motions: Doug Atkin, see ECF No. 26; Broward Motorsports Holdings LLC, see ECF No. 16; Gary Eberhard, see ECF No. 20; Alexander Enciso, see ECF No. 33; Scott Reynolds and SRR Fortress Capital LLC, see ECF No. 22; Fred and Elaine Khachi, Sasan Payvar, Dina Yaghmai, and Domenic Pesce, see ECF No. 34; Kevin Harte and Alfred Fenelle, see ECF No. 35; Margaretha Welkhammer, see ECF No. 25; and Daniel, Paul, and Mary Ann Yannes, see ECF No. 32. Kodak is a software and consumables company incorporated in New Jersey and headquartered in Rochester, New York. See Compl., ¶ 1.2 On July 27, 2020, Kodak alerted media in Rochester to a “new manufacturing initiative that could change the course of history for Rochester and the American people.” See id. ¶¶ 2, 27. According to Kodak, it meant to send the alert as “background only,” but inadvertently omitted that caveat, so local news reported it to the

public. Id. ¶ 27. A trading frenzy ensued: investors moved 1.65 million shares that day, up from 75,000 previously. Id. ¶ 28. At the very same time, and unbeknownst to the public, Kodak’s Board of Directors allegedly gave CEO James Continenza and CFO David Bullwinkle together 1.8 million stock options, convertible at a price between $3 and $12. See id. ¶¶ 3, 5, 34. Kodak’s shares closed at $2.62, making the options instantly profitable. Id. ¶ 3. On July 28, 2020, before trading began, RochesterFirst.com broke news of a $765 million loan from the United States International Development Finance Corporation (“DFC”), which Kodak would use to manufacture ingredients for COVID-19 drugs, the first of its kind under the Defense Production Act (“DPA”).3 See id. ¶ 4, 28. DFC signed a formal Letter of Interest (“LOI”)

that day, with financing subject to final due diligence, and held a press conference with Kodak officially announcing the deal. Id. ¶ 30. Continenza apparently told the Wall Street Journal that, despite never successfully manufacturing pharmaceuticals before, Kodak has “a long, long history in chemical and advanced materials—well over 100 years,” and could “get up and running quickly.” Id. ¶ 32.

2 I accept all facts in the Complaint as true for the purposes of this motion. I also consider “affidavits, depositions, stipulations, or other documents containing facts that would tend to establish the necessary elements for a transfer.” See Plum Tree, Inc. v. Stockment, 488 F.2d 754, 756-57 (3d Cir. 1973).

3 Kodak filed a loan application with DFC in mid-June 2020, pursuant to an executive order that delegated authority to DFC to “make loans . . . to create . . . industrial capabilities . . . needed to respond to the COVID-19 outbreak.” See Compl., ¶ 26. On July 29, 2020, Continenza appeared remotely on a CNBC show called Squawk Box, broadcast from New York City, to discuss the loan. Id. ¶ 33. When asked if it was a “done deal,” he purportedly responded: “We feel very comfortable that we can bank on it.” Id. When asked about the high trading volume on July 27, 2020, he continued: “I mean, obviously this has been a pretty tight kept secret . . . even until the last day, basically.” Id. And when the interviewer observed

that the deal did not look that way, he admitted: “Well, we knew for over a week.” Id. Kodak’s shares closed at $33.20, up 1,000% from two days earlier. Questions began to surface almost as quickly as the stock rose. On August 1, 2020, Reuters reported the “unusual” option grant. Quoting “a person familiar with the arrangement,” the grant “occurred because of an understanding” between Continenza and the Board of Directors “that had previously neither been listed in his employment contract nor made public.” See id. ¶¶ 5, 37. Kodak shares fell by $6.91 on the news. Id. ¶ 6. Then, on August 4, 2020, the website CQ Roll Call reported a letter from Senator Elizabeth Warren asking the SEC to investigate Kodak’s dealings with the DFC. According to that letter, Continenza purchased 46,737 shares [at $2.22] on June 23,

2020, “while the company was involved in secret negotiations with the government over a lucrative contract,” which “raises questions about whether [he] potentially made investment decisions based on material, non-public information.” Id. ¶ 7. Senator Warren also questioned Kodak’s allegedly inadvertent disclosure on July 27, 2020, which set off a chaotic trading day, and its decision to “ask[ ] reporters to remove the information” rather than reveal the deal to investors. Id. ¶¶ 8, 39- 40. On August 4, 2020, the Wall Street Journal revealed a nascent SEC investigation into “how Kodak controlled disclosure of the [DFC] loan.” Id. ¶ 9. According to the Journal, “[t]he SEC is also expected to examine the stock options granted to executives” that same day. Id. Likewise, the Journal reported a $116.3 million gift from Kodak Board member George Karfunkel to Congregation Chemdas Yisroel, “a small space attached to a three-story apartment building” in Brooklyn, which he founded. Karfunkel made the donation on July 29, 2020, the day Kodak’s share price peaked. Id. ¶ 42. It was “the single largest [gift] recorded to a religious group.” Id. A subsequent article in Mother Jones found that Karfunkel likely would “pocket a deduction between

$52.5 and $180 million” because of the synagogue’s tax-exempt status. As a result, Kodak’s shares closed at $14.40, down $29 since news of the option grant emerged three days earlier. Id. ¶ 11. On August 5, 2020, “[s]everal Congressional committees” sent a joint letter to Continenza regarding “DFC’s decision to award [the $765 million] loan to Kodak despite your company’s lack of pharmaceutical experience and the windfall gained by you and other company executives.” Id. ¶ 12. The letter called Continenza’s option grant “concerning” because the Board made it “prior to the DPA loan becoming public information, but while Kodak was in discussions regarding the loan.” Id. ¶ 45. On August 7, 2020, DFC rescinded its LOI, citing “[r]ecent allegations of wrongdoing.” Id. ¶ 13. Kodak responded with a press release announcing a special committee to

“oversee an internal review of recent activity by the Company . . . in connection with the . . . loan.” Id. ¶ 46. Kodak’s shares traded at $10.73 following these developments. Id. ¶ 14. Finally, on August 11, 2020, on a call to discuss second quarter finances, Continenza “repeatedly referred to the loan as a ‘potential loan,’” in contrast to his more confident statements on Squawk Box, allegedly causing Kodak stock to fall to $9.72. B. The Present Litigation and Pending Motions

On August 13, 2020, Tang filed this putative class action on behalf of all persons who acquired Kodak common stock between July 27, 2020, and August 7, 2020, the class period. Id. ¶ 48.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Smith v. McIver
22 U.S. 532 (Supreme Court, 1824)
Van Dusen v. Barrack
376 U.S. 612 (Supreme Court, 1964)
Leroy v. Great Western United Corp.
443 U.S. 173 (Supreme Court, 1979)
Van Cauwenberghe v. Biard
486 U.S. 517 (Supreme Court, 1988)
Stewart Organization, Inc. v. Ricoh Corp.
487 U.S. 22 (Supreme Court, 1988)
Delta Air Lines, Inc. v. Chimet, S.P.A.
619 F.3d 288 (Third Circuit, 2010)
In Re Link_A_Media Devices Corp.
662 F.3d 1221 (Federal Circuit, 2011)
Amica Mut. Ins. Co. v. Fogel
656 F.3d 167 (Third Circuit, 2011)
Lafferty v. St. Riel
495 F.3d 72 (Third Circuit, 2007)
Minstar, Inc. v. Laborde
626 F. Supp. 142 (D. Delaware, 1985)
Oxford First Corp. v. PNC Liquidating Corp.
372 F. Supp. 191 (E.D. Pennsylvania, 1974)
Windt v. Qwest Communications International, Inc.
529 F.3d 183 (Third Circuit, 2008)
Ricoh Co., Ltd. v. Honeywell, Inc.
817 F. Supp. 473 (D. New Jersey, 1993)
Job Haines Home for the Aged v. Young
936 F. Supp. 223 (D. New Jersey, 1996)
Crosley Corporation v. Hazeltine Corporation
122 F.2d 925 (Third Circuit, 1941)
Kisko v. Penn Central Transportation Co.
408 F. Supp. 984 (M.D. Pennsylvania, 1976)

Cite This Page — Counsel Stack

Bluebook (online)
TANG v. EASTMAN KODAK COMPANY, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tang-v-eastman-kodak-company-njd-2021.